Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes

NCT01157403 is registered in ClinicalTrials.gov with Lu Debin as lead sponsor.

NCT NCT01157403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01157403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes
Lead sponsor
Lu Debin
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2010
Completion date
August 31, 2014
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evidence of liver transplantation